<DOC>
	<DOCNO>NCT00197275</DOCNO>
	<brief_summary>The primary purpose study demonstrate lot-to-lot consistency 3 production lot GSK Biologicals ' Hib-MenAC ( Haemophilus influenzae type b meningococcal serogroups A C ) vaccine reconstitute Tritanrix™-HepB ( diphtheria , tetanus , pertussis , hepatitis B ) vaccine administer single injection .</brief_summary>
	<brief_title>Lot-to-lot Consistency Tritanrix™-HepB/Hib-MenAC &amp; Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ Infants</brief_title>
	<detailed_description>The study double blind . However active control vaccine Tritanrix™-HepB/Hiberix™ administer single-blind manner . Blood sample collect immunogenicity analysis . GSK Biologicals ' OPV vaccine administer concomitantly study vaccine 2 , 4 6 month age accord local country regulation . The study last approximately 5 month per subject</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Inclusion criterion : healthy male female , , include , 56 83 day age . Born gestation period 36 42 week Birth dose hepatitis B vaccine within first 72 hour life Exclusion criterion : plan administration/administration vaccine foreseen study protocol within 30 day first dose study vaccine , plan administration study period . Bacille CalmetteGuérin ( BCG ) vaccine receive first 2 week life . History OR previous vaccination OR know exposure since birth diphtheria , tetanus , pertussis , hepatitis B , Haemophilus influenzae type b and/or meningococcal disease . Any confirm suspected immunosuppressive immunodeficient condition , include human immunodeficiency virus ( HIV ) infection A family history congenital hereditary immunodeficiency History neurologic disorder seizures History allergic disease reaction likely exacerbate component vaccine</criteria>
	<gender>All</gender>
	<minimum_age>56 Days</minimum_age>
	<maximum_age>83 Days</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Haemophilus influenzae type b</keyword>
	<keyword>diphtheria</keyword>
	<keyword>tetanus</keyword>
	<keyword>Prophylaxis diphtheria</keyword>
	<keyword>pertussis</keyword>
	<keyword>hepatitis B</keyword>
	<keyword>meningococcal serogroups A &amp; C disease</keyword>
</DOC>